System and method for extraction and cryopreservation of bone marrow
Inventors
Woods, Erik John • Johnstone, Brian H. • GU, Dongsheng • Sherry, Aubrey Marie • Musall, Kelsey Gwen • Woods, John R. • Hardin, James • Hooks, Alan
Assignees
Interested in licensing this patent?
MTEC can help explore whether this patent might be available for licensing for your application.
Abstract
Methods are provided for extracting bone marrow cells from bone obtained from deceased donors, for preparing the bone marrow for cryopreservation and for obtaining desired cells from cryopreserved and fresh bone marrow.
Core Innovation
The claim describes manipulating environmental conditions of a cadaver to obtain stem cells from bone explanted from the cadaver, with at least 70% of the recovered stem cells remaining viable. The disclosure relates recovery viability to postmortem cooling, warm ischemia time, cold ischemia time, and bone-processing intervals, associating these timing parameters with CD34+ cell viability and colony-forming capacity. Operational timing constraints and processing conditions are designated as [procedural detail omitted for safety].
Available summary records present analytical data and regression models relating ischemia durations and body-cooling intervals to cell viability and colony-forming-unit outcomes. Because the background section is omitted from the provided documentation, the specific technical problem is not explicitly described in patent. The records evaluate the recovery of viable stem cells from deceased-donor bone.
Claims Coverage
The claim coverage includes two inventive features derived from one independent claim directed to cadaver-bone stem-cell recovery under controlled environmental and ischemia conditions.
Stem-cell viability threshold
The claim specifies that at least 70% of the stem cells recovered from bone explanted from the cadaver are viable.
Control of ischemia times and postmortem conditions
The claim relates postmortem cooling, warm ischemia time, cold ischemia time, and bone-processing intervals to recovered stem-cell viability, wherein operational timing constraints and processing conditions are designated as [procedural detail omitted for safety].
The independent claim centers on recovering stem cells from cadaver bone while maintaining the stated viability threshold through control of postmortem environmental conditions and ischemia times.
Stated Advantages
The claim states that at least 70% of the recovered stem cells from cadaver bone are viable under the claimed conditions.
Fewer recovered stem cells are viable when specified postmortem timing limits are exceeded than when the claimed timing conditions are met.
Documented Applications
Recovery of stem cells from bone explanted from a cadaver, including mesenchymal stem cells (MSCs) among the recovered cell populations.
Interested in licensing this patent?